178 related articles for article (PubMed ID: 33841104)
21. Pharmacological enhancement of glutamate transport reduces excitotoxicity in vitro.
Beller JA; Gurkoff GG; Berman RF; Lyeth BG
Restor Neurol Neurosci; 2011; 29(5):331-46. PubMed ID: 21846950
[TBL] [Abstract][Full Text] [Related]
22. Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging.
Hefendehl JK; LeDue J; Ko RW; Mahler J; Murphy TH; MacVicar BA
Nat Commun; 2016 Nov; 7():13441. PubMed ID: 27834383
[TBL] [Abstract][Full Text] [Related]
23. Up-regulated GLT-1 resists glutamate toxicity and attenuates glutamate-induced calcium loading in cultured neurocytes.
Liu CH; Jiao H; Guo ZH; Peng Y; Wang WZ
Basic Clin Pharmacol Toxicol; 2013 Jan; 112(1):19-24. PubMed ID: 22998524
[TBL] [Abstract][Full Text] [Related]
24. Effects of novel beta-lactam, MC-100093, and ceftriaxone on astrocytic glutamate transporters and neuroinflammatory factors in nucleus accumbens of C57BL/6 mice exposed to escalated doses of morphine.
Sari Y; Swiss GMS; Alrashedi FA; Baeshen KA; Alshammari SA; Alsharari SD; Ali N; Alasmari AF; Alhoshani A; Alameen AA; Childers WE; Abou-Gharbia M; Alasmari F
Saudi Pharm J; 2024 Jul; 32(7):102108. PubMed ID: 38868175
[TBL] [Abstract][Full Text] [Related]
25. β-Lactamase inhibitor, clavulanic acid, attenuates ethanol intake and increases glial glutamate transporters expression in alcohol preferring rats.
Hakami AY; Sari Y
Neurosci Lett; 2017 Sep; 657():140-145. PubMed ID: 28826758
[TBL] [Abstract][Full Text] [Related]
26. Effects of Chronic Hydrocodone Exposure and Ceftriaxone on the Expression of Astrocytic Glutamate Transporters in Mesocorticolimbic Brain Regions of C57/BL Mice.
Wong W; Sari Y
Toxics; 2023 Oct; 11(10):. PubMed ID: 37888720
[TBL] [Abstract][Full Text] [Related]
27. Effects of Ceftriaxone on Glial Glutamate Transporters in Wistar Rats Administered Sequential Ethanol and Methamphetamine.
Althobaiti YS; Alshehri FS; Almalki AH; Sari Y
Front Neurosci; 2016; 10():427. PubMed ID: 27713684
[TBL] [Abstract][Full Text] [Related]
28. Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders.
Roberts-Wolfe DJ; Kalivas PW
CNS Neurol Disord Drug Targets; 2015; 14(6):745-56. PubMed ID: 26022265
[TBL] [Abstract][Full Text] [Related]
29. Methylmercury alters the in vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells.
Mutkus L; Aschner JL; Syversen T; Aschner M
Biol Trace Elem Res; 2005 Dec; 107(3):231-45. PubMed ID: 16286679
[TBL] [Abstract][Full Text] [Related]
30. Beta-lactam antibiotic prevents tolerance to the hypothermic effect of a kappa opioid receptor agonist.
Rawls SM; Robinson W; Patel S; Baron A
Neuropharmacology; 2008 Oct; 55(5):865-70. PubMed ID: 18644397
[TBL] [Abstract][Full Text] [Related]
31. Effects of Administered Ethanol and Methamphetamine on Glial Glutamate Transporters in Rat Striatum and Hippocampus.
Alshehri FS; Althobaiti YS; Sari Y
J Mol Neurosci; 2017 Mar; 61(3):343-350. PubMed ID: 27888396
[TBL] [Abstract][Full Text] [Related]
32. The Relationship Between Glutamate Dynamics and Activity-Dependent Synaptic Plasticity.
Barnes JR; Mukherjee B; Rogers BC; Nafar F; Gosse M; Parsons MP
J Neurosci; 2020 Apr; 40(14):2793-2807. PubMed ID: 32102922
[TBL] [Abstract][Full Text] [Related]
33. Ceftriaxone attenuates cocaine relapse after abstinence through modulation of nucleus accumbens AMPA subunit expression.
LaCrosse AL; Hill K; Knackstedt LA
Eur Neuropsychopharmacol; 2016 Feb; 26(2):186-194. PubMed ID: 26706696
[TBL] [Abstract][Full Text] [Related]
34. Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation.
Abulseoud OA; Alasmari F; Hussein AM; Sari Y
Front Neurosci; 2022; 16():841036. PubMed ID: 35864981
[TBL] [Abstract][Full Text] [Related]
35. The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats.
Rawls SM; Tallarida R; Robinson W; Amin M
Br J Pharmacol; 2007 Aug; 151(7):1095-102. PubMed ID: 17592517
[TBL] [Abstract][Full Text] [Related]
36. Effects of glial glutamate transporter activator in formalin-induced pain behaviour in mice.
Alotaibi G; Rahman S
Eur J Pain; 2019 Apr; 23(4):765-783. PubMed ID: 30427564
[TBL] [Abstract][Full Text] [Related]
37. Beta-amyloid and brain-derived neurotrophic factor, BDNF, up-regulate the expression of glutamate transporter GLT-1/EAAT2 via different signaling pathways utilizing transcription factor NF-kappaB.
Rodriguez-Kern A; Gegelashvili M; Schousboe A; Zhang J; Sung L; Gegelashvili G
Neurochem Int; 2003; 43(4-5):363-70. PubMed ID: 12742080
[TBL] [Abstract][Full Text] [Related]
38. GLT-1 transporter: an effective pharmacological target for various neurological disorders.
Soni N; Reddy BV; Kumar P
Pharmacol Biochem Behav; 2014 Dec; 127():70-81. PubMed ID: 25312503
[TBL] [Abstract][Full Text] [Related]
39. Amoxicillin and amoxicillin/clavulanate reduce ethanol intake and increase GLT-1 expression as well as AKT phosphorylation in mesocorticolimbic regions.
Goodwani S; Rao PS; Bell RL; Sari Y
Brain Res; 2015 Oct; 1622():397-408. PubMed ID: 26168897
[TBL] [Abstract][Full Text] [Related]
40. Effects of Hydrocodone Overdose and Ceftriaxone on Astrocytic Glutamate Transporters and Glutamate Receptors, and Associated Signaling in Nucleus Accumbens as well as Locomotor Activity in C57/BL Mice.
Wong W; Sari Y
Brain Sci; 2024 Apr; 14(4):. PubMed ID: 38672013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
